Gewebeverstärkte Mikrokatheter zur Verwendung mit Mikroführungsdrähten für die Applikation von Platincoils, Stents, Thrombektomiesystemen sowie zur Thrombusaspiration.

    [Bildquelle: © peter neu | neuezeiten-werbeagentur.de]

    Vorteile

    • Progressiv gewebeverstärktes hydrophil beschichtetes Kathetermaterial optimiert die Navigierbarkeit und garantiert Stabilität
    • Mit 2 röntgendichten Spitzenmarkern verfügbar als 10er und 18er "Coilkatheter"
    • Als 2,4F bis 3,8F-Katheter einsetzbar für die Applikation von intrakraniellen Stents, Flow Divertern und Thrombektomiesystemen
    • Als VASCO+Aspi verfügbar für die Aspiration von Thromben auch mit großen Spritzen
    • Verfügbar in Längen von 140 cm und 155 cm als 1,9F bis 5,1F-Mikrokatheter

    Technische Daten


    ArtikelnummerProximal O.D -
    Distal O.D.
    I.D.Totale Länge
    (cm)
    Empfohlener
    Führungsdraht max.
    Anzahl an
    ORX Markern
    Kurve
    Vasco+10 (D-MP)2,2F bis 1,9F.017"155.014"2Straight (D),
    Multipurpose (MP)
    Vasco+10MH (D-MP)2,2F bis 1,9F.017"155.014"3Straight (D),
    Multipurpose (MP)
    Vasco+18 (D-MP)2,7F bis 2,1F.021"155.018"2Straight (D),
    Multipurpose (MP)
    Vasco+21 (D-MP)2,7F bis 2,4F.024"155.021"1Straight (D),
    Multipurpose (MP)
    Vasco+25 (D-MP)3,3F bis 3,0F.029"155.025"1Straiht (D),
    Multipurpose (MP)
    Vasco+28 (D-MP)3,4F bis 3,3F.032"155.028"1Straight (D),
    Multipurpose (MP)
    Vasco+35 (D-MMP94,0F bis 3,8F.040"135.035"1Straight (D),
    Multipurpose (MP)
    Vasco+35ASPI (D-MP)5,1F bis 5,1F.040"140.035"1Straight (D),
    Multipurpose (MP)

    Vasco+ is a reinforced micro-catheter intended: for injection of diagnostic or therapeutic products; to position pushable coils “SPIRALES” or detachable coils especially the ones of MDS « mechanical detachment system »; for the use of the self-expanding stent LEO+ or SILK+. Class III CE0297 in compliance with Medical Device Directive (MDD 93/42/EEC amended by 2007/47/EC). Manufactured by BALT EXTRUSION SAS. Carefully read the instructions for use before use. Not reimbursed. First CE marking: 2004. The self-expandable SILK+ stents and SILK Vista Baby are designed for the treatment of intracranial aneurysms and should be used only by clinicians trained in the placement of intracranial stents. Class III CE0297 in compliance with Medical Device Directive (MDD 93/42/EEC amended by 2007/47/EC).Manufactured by BALT EXTRUSION SAS. Carefully read the instructions for use before use. Not reimbursed. First CE marking:2012. The self-expandable LEO+/LEO+ Baby stent is designed for the treatment of intracranial aneurysms in association with embolization coils. Class III CE0297 in compliance with Medical Device Directive (MDD 93/42/EEC amended by 2007/47/EC). Manufactured by BALT EXTRUSION SAS. Carefully read the instructions for use before use. French reimbursement codes 3101316 and 3171593.First CE marking:2007 (LEO+),2012 (LEO+Baby) CATCH+ and CATCHView are designed for use in the flow restoration of patients with ischemic stroke due to large intracranial vessel occlusion. They are indicated to restore blood flow in the neurovasculature of patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA), who fail IV t-PA therapy or as a supplement treatment of initiated IV t-PA therapy. The CATCH+ and CATCHView thromboembolectomy devices should only be used by physicians trained in interventional neuroradiology and treatment of ischemic stroke. Class III CE0297 in compliance with Medical Device Directive (MDD 93/42/EEC amended by 2007/47/EC).Manufactured by BALT EXTRUSION SAS. Carefully read the instructions for use before use. Not reimbursed. First CE marking:2012 (CATCH+), 2018 (CATCHView). The Optima Coil System is intended for use in the peripheral and neuro-vasculature to endovascularly obstruct or occlude blood flow in vascular abnormalities of the neurovascular and peripheral vessels. Class III CE0297 in compliance with Medical Device Directive (MDD 93/42/EEC amended by 2007/47/EC).Manufactured by BALT USA LLC. Carefully read the instructions for use before use. French reimbursement code 3162217.First CE marking:2017. The Barricade Coil System (BCS) is intended for the endovascular embolization of intracranial aneurysms and other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae. The BCS is also intended for vascular occlusion of blood vessels within the neurovascular system to permanently obstruct blood flow to an aneurysm or other vascular malformation and for arterial and venous embolizations in the peripheral vasculature. The device should only be used by physicians who have undergone pre-clinical training in all aspects of BCS procedures as prescribed by Balt. Class III CE0297 in compliance with Medical Device Directive (MDD 93/42/EEC amended by 2007/47/EC). Manufactured by BALT USA, LLC. Carefully read the instructions for use before use. First CE-Mark: 2012.The content of this document, in particular data, information, trademarks and logos is BALT SAS and affiliate’s sole property. © 2019 BALT SAS and affiliates, all rights reserved. All representation and/or reproduction, whether in part or in full, is forbidden and would be considered a violation of BALT SAS and affiliates’ copyrights and other intellectual proprietary rights. This document with associated pictures is non-contractual and is solely dedicated to healthcare professionals and BALT’s distributors (BALT’s supplier’s distributors). The products commercialized by BALT shall exclusively be used in accordance with the instructions for use included in the boxes.